Cardiothoracic & vascular anesthesia

Rhomboid intercostal block or thoracic paravertebral block for postoperative recovery quality after video-assisted thoracic surgery: A prospective, non-inferiority, randomised controlled trial

Eur J AnaesthesiolPublished Randomised controlled trial

Primary result · Quality of recovery-40 scoreResult — go to the resultMean difference −1.6 95% CI −4.5 to 1.3

Authors' conclusion

Our study suggests that RIB was non-inferior to TPVB for the quality of recovery, with almost the same postoperative analgesic effect as TPVB after VATS.

Study context

Population
Patients aged 18 to 80 years, ASA I to III, scheduled for elective video-assisted thoracoscopic surgery (VATS); single hospital in China, March 2021 to August 202275 completed
Participants
80 patients
Comparison
Rhomboid intercostal block (RIB) vs thoracic paravertebral block (TPVB)
Primary endpoint
Quality of recovery-40 score (mean difference)
Follow-up
24 h postoperatively
Methodological detailsprospective, non-inferiority
  • Prospective
  • Non-inferiority

Primary result

Quality of recovery-40 score

Mean difference

−1.6

95% CI −4.5 to 1.3

RIB vs TPVB
mean difference −1.6 (95% CI −4.5 to 1.3)

Non-inferiority margin 6.3 as printed, not drawn

As reported in the abstract

Further findings

AUC of pain numeric rating scores (NRS) over time, at rest and on movement · 6, 12, 24 and 48 h postoperatively

AUC pain NRS on movement at 48 h
P = 0.046
No significant difference between groups (all P > 0.05), except on movement at 48 h

Postoperative sufentanil use · 0 to 24 h and 24 to 48 h

No statistical differences between groups (all P > 0.05)

Original publication

Rhomboid intercostal block or thoracic paravertebral block for postoperative recovery quality after video-assisted thoracic surgery: A prospective, non-inferiority, randomised controlled trial. Eur J Anaesthesiol. Published 28 June 2023. doi:10.1097/eja.0000000000001872

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.